Watch OCUL. Know when insiders buy.
One email the day a filing lands. Free.
OCUL
OCULAR THERAPEUTIX, INC
6.48
−0.17 −2.56%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
42
WATCH · insiders 30, shorts 54
Insiders, 90 days
−$568K
net selling · 0 buys, 8 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.4BP/E —DIV YIELD —FCF YIELD -17.93%REV TTM $52.1M −8.1%NET INCOME −$301.4MNET CASH $580.6M52W 6.29 – 16.11SEC XBRL · TTM TO Invalid Date
One year, everything drawn on
Insider buyInsider sellCongress buy, above the lineCongress sell, below10-K / 10-Q filedHOVER A MARKER FOR THE FILING
THE WORK ORDER · 2026-10-21
Insiders (90d): $568K net selling
Shorts (latest report): 28.1M short · −460K last period
Every line of the math42WATCH
Insider activity
ALL 8| Date | Insider | Type | Value |
|---|---|---|---|
| Oct 8 | Chief Legal Officer | Sell | $87K |
| Oct 2 | Chief Development Officer | Sell | $70K |
| Oct 2 | Chief Scientific Officer | Sell | $77K |
| Aug 31 | Chief Operating Officer | Sell | $11K |
| Aug 24 | Chief Strategy Officer | Sell | $20K |
| Aug 24 | Chief Development Officer | Sell | $33K |